What Do AMLO & Biden Have to Gain in Today’s Meeting?
A Latin America Advisor Q&A featuring viewpoints on the outlook for President Biden’s meeting with Mexican President López Obrador.
Andrew Rudman
United States | Managing Director, Monarch Global Strategies
˙
Andrew Rudman is the managing director at Monarch Global Strategies, a boutique advisory firm in Washington DC, where he advises clients on public policy and regulatory challenges related to market access in the Americas for the pharmaceutical, medical device, and nutritional supplement sectors.
Previous to joining Monarch, Rudman was deputy vice president for the Western Hemisphere at the Pharmaceutical Research and Manufacturers of America, executing policy advocacy strategies for member companies across the hemisphere. Prior to this, he began his public sector career as a foreign service officer with the US Department of State and later took on the role of director of the Office of NAFTA and Inter-American Affairs in the Department of Commerce’s International Trade Administration.
He holds an MA in Latin American Studies from Tulane University and a BA in Government from Colby College.
Rudman is a frequent commentator for the Latin America Advisor.
Analysis See all
Will Patent Waivers Make Covid Vaccines More Accessible?
A Latin America Advisor Q&A on Biden’s decision to support waiving patents for Covid-19 vaccines and its implications for Latin America.
Why Don’t More Mexicans Have Health Coverage?
A Financial Services Advisor Q&A featuring experts’ viewpoints on public and private health insurance coverage in Mexico.